Tutorials › CAS Exam 9 - Risk Management for Actuaries › Selecting Plausible Management Actions

CAS Exam 9 · Integrated Stress and Scenario Analysis · Tutorial 962 of 995

Selecting Plausible Management Actions

Learn how to identify which management actions are executable in a stress scenario, by when, and subject to which prerequisites.

Advanced 10 min read

What You'll Learn

  • Define a plausible management action in a stress scenario
  • Screen reinsurance, hedging, asset sales, expense reduction, and capital raising
  • Map prerequisites, dependencies, and lead times to decision deadlines
  • Distinguish liquidity actions from actions that may affect capital or risk
  • Identify when an action is conditional, unavailable, or limited to future exposures

Why Action Feasibility Matters

A stressed insurer may have several apparent responses: buy reinsurance, hedge a market exposure, sell assets, reduce expenses, or raise capital. But a response that is attractive in principle is not necessarily available when it is needed. A contract may not be effective until after the loss event; an asset sale may require approvals and settlement time; or a capital raise may depend on investor interest that has not been secured.

Action selection therefore starts with feasibility, timing, and purpose, not with an assumption that every proposed measure can be implemented immediately. The stress scenario supplies the relevant events and deadlines. For each proposed action, ask what it is intended to address, what must happen before it can be implemented, and whether it can be completed before the relevant deadline. This is aligned with the CAS Exam 9 (Risk Management for Actuaries) syllabus.

Definition: A management action is a deliberate intervention available to the insurer, such as purchasing reinsurance, entering a hedge, selling assets, reducing expenses, or raising capital. An action is plausible in a stress scenario only when the insurer has a credible authority and execution path, the necessary prerequisites can be met, and the action can take effect in time for the purpose claimed. Plausibility does not by itself establish that the action is beneficial or quantify its effect.

Screen Actions Against Their Purpose and Deadline

A useful screen begins by defining the problem precisely. A projected cash shortfall due in a week is not the same problem as a capital shortfall measured at the end of a quarter. An action that may help one cannot automatically be credited toward the other. In particular, selling assets can produce cash while also changing the assets that remain; the capital consequence depends on the terms of the sale and the applicable measurement basis.

For every action, record the decision deadline, expected effective date, and relevant prerequisites. Distinguish an action that is already authorized and executable from one that depends on unresolved conditions. A useful classification is available (the necessary gates are satisfied or have a credible timely path), conditional (one or more material gates remain open), or unavailable for the stated deadline. “Unavailable by the deadline” does not mean impossible forever; it means the action cannot support that particular decision or need on the stated timeline.

ActionTypical feasibility questionsTiming issue to check
ReinsuranceCan the insurer obtain terms, satisfy underwriting requirements, obtain approvals, and execute the contract?When does coverage incept, and does it cover the event or exposure being considered?
HedgingAre the strategy, counterparties, limits, and collateral arrangements authorized and available?How long do approval, execution, and collateral arrangements take?
Asset saleAre the assets unencumbered and saleable, and are internal approvals and market access available?When will the trade settle and cash be available?
Expense reductionCan contracts, staffing, systems, and customer obligations be changed lawfully and operationally?When do savings begin, rather than when is the decision announced?
Capital raisingAre investors or lenders available, and are board, regulatory, and transaction approvals required?When will funds be committed, approved, and received?

Representing Dependencies and Lead Times

The completion date depends on which steps must occur in sequence and which can proceed at the same time. Suppose an action requires a risk review followed by approval followed by execution. If those steps take \(a\), \(b\), and \(c\) days, respectively, and cannot overlap, the earliest completion time is their sum. If two independent prerequisites can proceed in parallel, the action must wait for the slower one, not the sum of both.

$$ T_{\text{sequential}} = a+b+c, \qquad T_{\text{parallel prerequisites}} = \max(a,b) $$

This follows from the definition of a dependency. A sequential step cannot start until the preceding step is complete, so each duration adds to the elapsed time. Parallel steps start together, and both must be complete before the next dependent step can proceed; that occurs when the longer step finishes. For a process with several dependencies, map the paths and identify the longest required path to completion. Use consistent time units: a business-day settlement period cannot be treated as a calendar-day period without checking the dates.

1
State the need and deadline.
Specify whether the action is intended to address a cash need, an exposure that continues after the stress event, a capital requirement, or another stated objective.
2
Map prerequisites.
List required approvals, counterparties, data, contracts, collateral, investor commitments, settlement, and operational changes.
3
Calculate the earliest credible date.
Add durations for required sequential steps; use the longest duration for independent parallel steps. Include any waiting period before an action can legally or contractually take effect.
4
Classify and qualify the action.
Record whether it is available, conditional, or unavailable for the stated deadline, and state what it can and cannot address.

Worked Example: Screening Reinsurance and a Hedge

Worked Example: Screening Reinsurance and a Hedge

A hypothetical insurer identifies a severe wind-event stress on day 0. The event has already occurred, but further claims and market effects are expected over the next 30 days. Management needs to identify actions that can be implemented by day 10. Assume all durations below are calendar days, every listed step is required, and there are no other unlisted delays.

A new reinsurance contract requires 2 days to prepare exposure data, then 4 days for market negotiation, then 2 days for approval and execution. It would incept on day 10. A proposed hedge requires 1 day for risk authorization, 2 days for execution after authorization, and 1 day to establish collateral arrangements after execution. It requires $5 million of collateral. The insurer has $4 million available; a $2 million internal liquidity transfer can be completed in 1 day. Assume the transfer can proceed in parallel with hedge authorization, and that the hedge is otherwise within approved counterparty limits.

Method. Map the required steps, calculate the earliest dates, then test the effective date and resources against the stated need. This avoids treating a proposed action as immediately effective or assuming that a later contract covers an event that has already occurred.

Reinsurance timing. The required steps are sequential, so the elapsed time is \(2+4+2=8\) days. The contract incepts on day 10 under the stated terms. It therefore cannot cover the event that occurred on day 0. It may be relevant to exposures after inception, subject to the contract terms, but it cannot be represented as transferring the already-occurring event’s losses.

Hedge timing. Authorization, execution, and collateral setup are sequential, so they take \(1+2+1=4\) days. The internal transfer takes 1 day and runs in parallel with authorization. The hedge cannot proceed to completion until both the hedge steps and the transfer are complete; the required time is \(\max(4,1)=4\) days. By day 4, collateral resources are \(4+2=6\) million dollars, which exceed the required \(5\) million dollars by \(1\) million dollars.

Conclusion and check. The hedge has a credible path to completion by day 4, before the day-10 deadline, provided the transfer and all stated approvals occur as assumed. The reinsurance contract also incepts by day 10, but it does not cover the day-0 event. The distinction is important: meeting a deadline is not enough if the action’s coverage or purpose does not match the loss being addressed. The collateral check is \(6\geq5\) million dollars, so the hedge meets its stated collateral prerequisite.

Common mistake. Counting the reinsurance contract as protection for the day-0 event because its preparation starts on day 0 is incorrect. Coverage begins at the stated inception date, day 10; preparation time does not make coverage retroactive.

Worked Example: Asset Sale or Capital Raise for a Cash Deadline

Worked Example: Asset Sale or Capital Raise for a Cash Deadline

A hypothetical insurer must have at least $7.5 million of additional cash available by day 10. Day 0 is Monday, and all timing is stated in business days. An eligible, unencumbered asset sale requires 1 business day for approval, 1 business day for execution after approval, and settlement 2 business days after the trade. Expected net proceeds after transaction costs are $7.9 million. Assume the insurer’s post-sale liquidity floor remains satisfied.

A proposed capital raise requires 4 business days for board approval, then 3 business days for regulatory approval, then 5 business days for placement, followed by 2 business days to settle. Assume these steps are sequential and there is no committed investor or expedited approval.

Method. Compare each action’s earliest cash-availability date with the cash deadline, and separately check whether its amount meets the need. This avoids confusing an announced transaction with settled funds.

Asset sale. Approval takes 1 business day and execution takes a further 1, so the trade occurs after 2 business days. Settlement takes 2 more business days, making cash available after \(1+1+2=4\) business days. Since day 10 is 10 business days after day 0, the sale settles 6 business days before the deadline. Its net proceeds are $7.9 million, exceeding the $7.5 million need by \(7.9-7.5=0.4\) million dollars.

Capital raise. The steps take \(4+3+5+2=14\) business days. Funds therefore arrive 4 business days after the day-10 deadline. On the stated assumptions, the raise cannot solve this cash need by the deadline.

Conclusion and check. The asset sale is feasible for the stated cash need, conditional on approval, execution, settlement, and the assumed liquidity-floor test. The capital raise is too slow. The sale’s $7.9 million proceeds exceed the required $7.5 million; the raise’s 14-business-day lead time exceeds the 10-business-day window.

Common mistake. Treating the capital raise as timely because board approval takes only 4 days omits the remaining required steps. The correct completion time is 14 business days, not 4.

Worked Example: Building a Feasible Action Sequence

Worked Example: Building a Feasible Action Sequence

A hypothetical insurer faces a stress that continues for at least 45 days. It expects a cash shortfall on day 7 and must complete a capital review by day 30. Management is considering three actions. An asset sale can provide cash on day 5 if approved and settled as specified. Reinsurance for new losses requires 12 days to negotiate and execute and can incept on day 12; it cannot cover losses incurred before inception. An expense program requires 3 days for approval and 28 days to implement, with savings beginning only after implementation. Assume the expense steps are sequential and the actions do not have additional dependencies.

Method. Match each action to the need it can address, calculate its completion date, and retain conditions that must be verified. This avoids assuming that an action for liquidity necessarily resolves a capital concern, or that a future-facing action erases losses already incurred.

Asset sale and day-7 cash. Cash is available on day 5, which is 2 days before the day-7 shortfall. The sale is timely for liquidity if approval, settlement, and the post-sale liquidity assessment are completed as assumed. It should not be described as a capital improvement without a separate assessment of sale price, accounting treatment, and the relevant capital measure.

Reinsurance and continuing losses. The contract can incept on day 12. That is after the day-7 cash shortfall and after losses incurred before inception. It may be considered for losses arising from covered exposures after day 12, subject to the actual terms and successful placement. It cannot be counted as a day-7 cash response or as cover for earlier losses.

Expense program and day-30 review. The sequential steps take \(3+28=31\) days. Savings begin on day 31, one day after the capital review. Therefore the program cannot be credited as producing savings by day 30 on these assumptions. If management starts the process earlier than day 0, or the implementation plan changes, the timing would need to be reassessed.

Conclusion and check. The sale has a plausible path to the day-7 liquidity need; reinsurance can only address eligible future losses after day 12; the expense program’s savings begin on day 31, after the day-30 review. The computed dates are \(5\leq7\), \(12>7\), and \(31>30\), respectively. The three actions therefore have different roles and cannot be treated as interchangeable.

Common mistake. Counting expense savings from the approval date would imply savings by day 3, but the stated assumption is that savings start only after the 28-day implementation period. The correct start date is day 31.

What Makes an Action Credible

A timing calculation is necessary but not sufficient. A credible action record should identify the owner, decision authority, key prerequisite, evidence that the prerequisite is achievable, and a trigger for reconsidering the action if the plan slips. For example, “raise capital in 20 days” is not a complete plan if no investor has been approached and regulatory approval is unresolved. In that case, the action is conditional, and its assumed completion date should not be presented as certain.

Actions also need to be consistent with the scenario. New reinsurance may protect a continuing exposure only if its terms cover that exposure and its inception date is early enough. A hedge needs a defined exposure, authorization, counterparty capacity, and a workable collateral plan. An asset sale needs saleable assets and settlement before cash is required. Expense reduction must account for contractual, regulatory, and operational constraints. Capital raising must account for approvals and the time until funds are actually available.

A common analytical error is to combine actions that cannot all occur as planned. For instance, a projected asset sale may rely on the same assets needed to support a different liquidity contingency. Another error is to describe a possible action as committed when it still depends on an open approval or market transaction. Record such dependencies openly; do not silently assume them away.

Key takeaway: Select an action only for a stated purpose and deadline, then test its authority, prerequisites, dependencies, effective date, and operational credibility. Keep conditional actions visibly conditional, and do not credit an action for losses, cash needs, or dates that it cannot address.

Check Your Understanding

For each hypothetical situation, identify the feasible action for the stated deadline and the key qualification. Durations are as given; do not assume unlisted steps are complete.

  1. A cash need of $4.0 million is due in 6 business days. An asset sale requires 1 day for approval, 1 day for execution, and 2 days for settlement; net proceeds are $4.3 million. A capital raise requires 9 business days before settlement. Which action can meet the need, and by how much do proceeds exceed it? (Answer: The asset sale can meet it in 4 business days, with a $0.3 million surplus; the capital raise is too late.)
  2. A hedge requires 2 days for approval and then 3 days for execution. Collateral setup takes 4 days and can begin in parallel with approval. What is the earliest completion time, assuming execution cannot begin before approval? (Answer: 5 days: approval plus execution takes \(2+3=5\), while the parallel collateral setup takes 4, so the controlling path is 5 days.)
  3. A reinsurance contract requires 3 days for data preparation, 5 days for negotiation, and 2 days for execution, all sequential. It incepts on completion. A loss occurred on day 0, and management asks whether the contract can cover it. What is the earliest inception and the coverage conclusion? (Answer: Day 10; it cannot cover the day-0 loss under the stated inception assumption.)
  4. An expense reduction plan requires 2 days for approval and 18 days for implementation, sequentially. Savings begin at implementation completion. A review occurs on day 19. Are savings available for that review? (Answer: No. Savings begin on day 20, one day after the review.)
  5. A proposed capital raise needs 3 days for board approval, 4 days for regulatory approval, and 6 days for placement, sequentially, followed by 2 days for settlement. A capital review is due on day 14. Is the raise timely, and what prerequisite distinguishes committed funds from a proposal? (Answer: No; funds arrive on day 15. A credible investor commitment, along with required approvals and completed settlement, is needed before treating funds as available.)
Clinical Biostats